Literature DB >> 10838851

Case report. Meningitis due to Cryptococcus neoformans var. neoformans serotype AD associated with pulmonary tuberculosis.

S Nagrajan, H C Gugnani, T Kowshik.   

Abstract

A case of meningitis in a 38-year old male with pulmonary tuberculosis is described. Cryptococcus neoformans was isolated from the cerebrospinal fluid. The isolate belonged to variety neoformans serotype AD. The patient died before any antimycotic therapy could be instituted.

Entities:  

Mesh：

Year:  2000        PMID： 10838851     DOI： 10.1046/j.1439-0507.2000.00544.x

Source DB:  PubMed          Journal:  Mycoses        ISSN： 0933-7407            Impact factor:   4.377


  5 in total

1.  Concurrent cryptococcal meningitis and disseminated tuberculosis occurring in an immunocompetent male.

Authors:  Marcellin Musabende; Constance Mukabatsinda; Elisabeth D Riviello; Onyema Ogbuagu
Journal:  BMJ Case Rep       Date:  2016-02-25

2.  Cryptococcosis and tuberculosis co-infection at a university hospital in Taiwan, 1993-2006.

Authors:  C-T Huang; Y-J Tsai; J-Y Fan; S-C Ku; C-J Yu
Journal:  Infection       Date:  2010-07-27       Impact factor: 3.553

Review 3.  Fatal Disseminated Tuberculosis and Concurrent Disseminated Cryptococcosis in a Ruxolitinib-treated Patient with Primary Myelofibrosis: A Case Report and Literature Review.

Authors:  Asuka Ogai; Kazuma Yagi; Fumimaro Ito; Hideharu Domoto; Tetsuya Shiomi; Kenko Chin
Journal:  Intern Med       Date:  2021-09-25       Impact factor: 1.282

4.  Miliary tuberculosis with co-existing pulmonary cryptococcosis in non-HIV patient without underlying diseases: a case report.

Authors:  Toyomitsu Sawai; Takumi Nakao; Satoru Koga; Shotaro Ide; Sumako Yoshioka; Nobuko Matsuo; Hiroshi Mukae
Journal:  BMC Pulm Med       Date:  2018-01-16       Impact factor: 3.317

5.  Tuberculous peritonitis and pleurisy accompanied by pulmonary cryptococcosis: A case report.

Authors:  Jian-Kun Chen; Shu-Bin Cai; Qian Cai; Hang Qi; Ji-Qiang Li
Journal:  J Int Med Res       Date:  2018-05-13       Impact factor: 1.671
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.